Literature DB >> 30415061

Acetylcholinesterase inhibitor from Anthocleista vogelii leaf extracts.

O S Ajayi1, M A Aderogba2, E M Obuotor3, R R T Majinda4.   

Abstract

BACKGROUND: Anthocleista vogelii (Planch) is used in folk medicine in conditions related to inflammation and oxidative stress. This suggests that some of its constituents could possess ability to reduce oxidative damage to cells and ameliorate inflammatory conditions which are two prominent features in the brain of a person suffering from Alzheimer's disease.
AIM OF STUDY: The leaf extracts were investigated for their bioactive constituents in our quest for novel compounds for the management of Alzheimer's disease.
MATERIALS AND METHODS: Anthocleista vogelii crude leaf extract obtained from 80% methanol was successively partitioned with n-hexane, dichloromethane (DCM), ethyl acetate (EtOAc) and n-butanol. This gave four solvent fractions of the crude extract. These fractions and isolated compound were subjected to acetylcholinesterase (AChE) inhibitory activity test using the microplate assay method. The structure of the isolated compound was determined using spectroscopic methods (1D and 2D NMR, and MS).
RESULTS: The results of the acetylcholinesterase inhibitory assay revealed that n-BuOH and ethyl acetate fractions had the best activity with IC50 of 564.58 and 727.63 µg/mL respectively. Activity directed fractionation of each of these fractions led to the isolation of the same compound identified as a C-glucosylflavone; isovitexin-7-O-methyl ether (swertisin). This rare C-glucosylflavone co-exist as two rotamers and exhibited duplication of NMR signals. It is reported from this plant for the first time. Swertisin displayed better acetylcholinesterase inhibitory activity with IC50 of 32.09 µg/mL than physostigmine (eserine) with IC50 of 56.09 µg/mL used as a standard.
CONCLUSIONS: This study reports isolation and characterization of a rare C-glycosylflavone; isovitexin-7-O-methyl ether (swertisin). Isolated compound exhibited duplication of NMR signals and better acetylcholinesterase inhibitory activity than eserine used as a standard. The activity exhibited by this compound suggests that it could be useful in the management of Alzheimer's disease.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase; Anthocleista vogelii; C-glucosylflavone; Loganiaceae; Rotamers; Swertisin

Mesh:

Substances:

Year:  2018        PMID: 30415061     DOI: 10.1016/j.jep.2018.11.009

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Combining In Silico and In Vitro Studies to Evaluate the Acetylcholinesterase Inhibitory Profile of Different Accessions and the Biomarker Triterpenes of Centella asiatica.

Authors:  Nor Atiqah Jusril; Ain Nur Najihah Muhamad Juhari; Syahrul Imran Abu Bakar; Wan Mazlina Md Saad; Mohd Ilham Adenan
Journal:  Molecules       Date:  2020-07-24       Impact factor: 4.411

2.  Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg.

Authors:  Jeong Hyun Heo; Bo Hyun Eom; Hyung Won Ryu; Myung-Gyun Kang; Jong Eun Park; Doo-Young Kim; Jung-Hee Kim; Daeui Park; Sei-Ryang Oh; Hoon Kim
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

3.  Revealing the Acetylcholinesterase Inhibitory Potential of Phyllanthus amarus and Its Phytoconstituents: In Vitro and in Silico Approach.

Authors:  Kolade O Faloye; Shafi Mahmud; Emmanuel G Fakola; Yemisi M Oyetunde; Sunday J Fajobi; Jeremiah P Ugwo; Ayobami J Olusola; Samson O Famuyiwa; Oluwabukunmi G Olajubutu; Temitope I Oguntade; Ahmad J Obaidullah
Journal:  Bioinform Biol Insights       Date:  2022-08-26

4.  Acetylcholinesterase and monoamine oxidase-B inhibitory activities by ellagic acid derivatives isolated from Castanopsis cuspidata var. sieboldii.

Authors:  Jong Min Oh; Hyun-Jae Jang; Myung-Gyun Kang; Soobin Song; Doo-Young Kim; Jung-Hee Kim; Ji-In Noh; Jong Eun Park; Daeui Park; Sung-Tae Yee; Hoon Kim
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.